{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T12:03:46Z","timestamp":1795089826676,"version":"4.10.2"},"reference-count":139,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2018.00124","type":"journal-article","created":{"date-parts":[[2018,4,24]],"date-time":"2018-04-24T04:39:09Z","timestamp":1524544749000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":44,"title":["Beyond the Biomarker: Understanding the Diverse Roles of Human Epididymis Protein 4 in the Pathogenesis of Epithelial Ovarian Cancer"],"prefix":"10.3389","volume":"8","author":[{"given":"Nicole E.","family":"James","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clinton","family":"Chichester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer R.","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,4,24]]},"reference":[{"key":"B1","first-page":"1","article-title":"Cancer facts fig. 2016","volume":"1","year":"2016","journal-title":"Am Cancer Soc"},{"key":"B2","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s10637-012-9837-3","article-title":"Investigational agents in development for the treatment of ovarian cancer","volume":"31","author":"Westin","year":"2013","journal-title":"Invest New Drugs"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1038\/sj.onc.1205363","article-title":"The putative ovarian tumour marker gene HE4 (WFDC2), is expressed in normal tissues and undergoes complex alternative splicing to yield multiple protein isoforms","volume":"21","author":"Bingle","year":"2002","journal-title":"Oncogene"},{"key":"B4","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/1465-9921-7-61","article-title":"WFDC2 (HE4): a potential role in the innate immunity of the oral cavity and respiratory tract and the development of adenocarcinomas of the lung","volume":"7","author":"Bingle","year":"2006","journal-title":"Respir Res"},{"key":"B5","first-page":"3695","article-title":"The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma","volume":"63","author":"Helistr\u00f6m","year":"2003","journal-title":"Cancer Res"},{"key":"B6","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ygyno.2008.08.031","article-title":"A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass","volume":"112","author":"Moore","year":"2009","journal-title":"Gynecol Oncol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1097\/IGC.0000000000000218","article-title":"The role of HE4 in ovarian cancer follow-up: a review","volume":"24","author":"Piovano","year":"2014","journal-title":"Int J Gynecol Cancer"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1700135","DOI":"10.1002\/prca.201700135","article-title":"Discovery and validation of novel protein biomarkers in ovarian cancer patient urine","volume":"9","author":"Sandow","year":"2018","journal-title":"Proteomics Clin Appl"},{"key":"B9","doi-asserted-by":"publisher","first-page":"403","DOI":"10.3892\/or.2014.3549","article-title":"Promotive role of recombinant HE4 protein in proliferation and carboplatin resistance in ovarian cancer cells","volume":"33","author":"Wang","year":"2015","journal-title":"Oncol Rep"},{"key":"B10","doi-asserted-by":"crossref","first-page":"729","DOI":"10.18632\/oncotarget.6327","article-title":"Overexpression of HE4 (human epididymis protein 4) enhances proliferation, invasion and metastasis of ovarian cancer","volume":"7","author":"Zhu","year":"2015","journal-title":"Oncotarget"},{"key":"B11","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S1995-7645(13)60055-3","article-title":"Effect of WFDC 2 silencing on the proliferation, motility and invasion of human serous ovarian cancer cells in vitro","volume":"6","author":"Zhu","year":"2013","journal-title":"Asian Pac J Trop Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/jog.13181","article-title":"Role of human epididymis protein 4 in chemoresistance and prognosis of epithelial ovarian cancer","volume":"43","author":"Lee","year":"2017","journal-title":"J Obstet Gynaecol Res"},{"key":"B13","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1097\/IGC.0000000000000078","article-title":"Human epididymis protein 4 inhibits proliferation of human ovarian cancer cells via the mitogen-activated protein kinase and phosphoinositide 3-kinase\/AKT pathways","volume":"24","author":"Kong","year":"2014","journal-title":"Int J Gynecol Cancer"},{"key":"B14","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.bbrc.2012.02.008","article-title":"Human epididymis protein 4 (HE4) plays a key role in ovarian cancer cell adhesion and motility","volume":"419","author":"Lu","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"B15","doi-asserted-by":"publisher","first-page":"3574","DOI":"10.1038\/srep03574","article-title":"HE4 (WFDC2) gene overexpression promotes ovarian tumor growth","volume":"4","author":"Moore","year":"2014","journal-title":"Sci Rep"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1158\/1535-7163.MCT-07-0120","article-title":"Targeting the AKT protein kinase for cancer chemoprevention","volume":"6","author":"Crowell","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"B17","doi-asserted-by":"publisher","first-page":"7391","DOI":"10.1038\/sj.onc.1209100","article-title":"AKT signaling in normal and malignant cells","volume":"24","author":"Testa","year":"2005","journal-title":"Oncogene"},{"key":"B18","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13048-016-0240-0","article-title":"HE4 promotes collateral resistance to cisplatin and paclitaxel in ovarian cancer cells","volume":"9","author":"Ribeiro","year":"2016","journal-title":"J Ovarian Res"},{"key":"B19","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/20459","article-title":"The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis","volume":"399","author":"Maxwell","year":"1999","journal-title":"Nature"},{"key":"B20","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/S0968-0004(98)01344-9","article-title":"Oncogenic alterations of metabolism","volume":"24","author":"Dang","year":"1999","journal-title":"Trends Biochem Sci"},{"key":"B21","first-page":"5830","article-title":"Overexpression of hypoxia-inducible factor 1\u03b1 in common human cancers and their metastases","volume":"59","author":"Zhong","year":"1999","journal-title":"Cancer Res"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.4161\/cbt.4.10.2195","article-title":"Targeting hypoxia and angiogenesis through HIF-1\u03b1 inhibition","volume":"4","author":"Diaz-Gonzalez","year":"2005","journal-title":"Cancer Biol Ther"},{"key":"B23","doi-asserted-by":"publisher","first-page":"3279","DOI":"10.1038\/sj.onc.1210421","article-title":"MAP kinase signalling pathways in cancer","volume":"26","author":"Dhillon","year":"2007","journal-title":"Oncogene"},{"key":"B24","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1038\/msb4100012","article-title":"Phosphotyrosine interactome of the ErbB-receptor kinase family","volume":"1","author":"Schulze","year":"2005","journal-title":"Mol Syst Biol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1177\/1533034616666644","article-title":"Clinical significance of serum HE4, CA125, CA724, and CA19-9 in patients with endometrial cancer","volume":"16","author":"Bian","year":"2016","journal-title":"Technol Cancer Res Treat"},{"key":"B26","doi-asserted-by":"publisher","first-page":"260","DOI":"10.17772\/gp\/62356","article-title":"The role of HE4 in differentiating benign and malignant endometrial pathology","volume":"87","author":"Gasiorowska","year":"2016","journal-title":"Ginekol Pol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"6026","DOI":"10.3390\/ijms14036026","article-title":"HE4 (WFDC2) promotes tumor growth in endometrial cancer cell lines","volume":"14","author":"Li","year":"2013","journal-title":"Int J Mol Sci"},{"key":"B28","doi-asserted-by":"publisher","first-page":"4973","DOI":"10.1007\/s13277-015-4324-z","article-title":"The role of HE4 in endometrial cancer recurrence: how to choose the optimal follow-up program","volume":"37","author":"Angioli","year":"2016","journal-title":"Tumour Biol"},{"key":"B29","first-page":"256","article-title":"[The importance of HE4 in differential diagnosis of endometrial cancer]","volume":"80","author":"Min\u00e1\u0159","year":"2015","journal-title":"Ces Gynekol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12885-015-1028-0","article-title":"Serum HE4 detects recurrent endometrial cancer in patients undergoing routine clinical surveillance","volume":"15","author":"Brennan","year":"2015","journal-title":"BMC Cancer"},{"key":"B31","doi-asserted-by":"publisher","first-page":"4156","DOI":"10.1007\/s13277-015-3049-3","article-title":"Utility of tumor marker HE4 as prognostic factor in endometrial cancer: a single-center controlled study","volume":"36","author":"Capriglione","year":"2015","journal-title":"Tumour Biol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1111\/aogs.12235","article-title":"HE4 and CA125 levels in the preoperative assessment of endometrial cancer patients: a prospective multicenter study (ENDOMET)","volume":"92","author":"Antonsen","year":"2013","journal-title":"Acta Obstet Gynecol Scand"},{"key":"B33","first-page":"327","article-title":"CA125 and HE4 levels in a Czech female population diagnosed with endometrial cancer in preoperative management","volume":"34","author":"Presl","year":"2014","journal-title":"Anticancer Res"},{"key":"B34","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.ygyno.2013.10.036","article-title":"Serum HE4 as a prognostic marker in endometrial cancer \u2013 a population based study","volume":"132","author":"Brennan","year":"2014","journal-title":"Gynecol Oncol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"142.e1","DOI":"10.1016\/j.ajog.2013.04.014","article-title":"Predictive value of serum human epididymis protein 4 and cancer antigen 125 concentrations in endometrial carcinoma","volume":"209","author":"Saarelainen","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.7314\/APJCP.2016.17.3.1489","article-title":"Association of serum HE4 with primary tumor diameter and depth of myometrial invasion in endometrial cancer patients at Rajavithi hospital","volume":"17","author":"Prueksaritanond","year":"2016","journal-title":"Asian Pac J Cancer Prev"},{"key":"B37","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.ygyno.2011.10.025","article-title":"Correlation of serum HE4 with tumor size and myometrial invasion in endometrial cancer","volume":"124","author":"Kalogera","year":"2012","journal-title":"Gynecol Oncol"},{"key":"B38","first-page":"177","article-title":"Utility of pelvic MRI and tumor markers HE4 and CA125 to predict depth of myometrial invasion and cervical involvement in endometrial cancer","volume":"9","author":"Zamani","year":"2015","journal-title":"J Family Reprod Health"},{"key":"B39","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/1477-7819-12-169","article-title":"Diagnostic value of serum HE4 in endometrial cancer: a meta-analysis","volume":"12","author":"Bie","year":"2014","journal-title":"World J Surg Oncol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"187","DOI":"10.15430\/JCP.2016.21.4.302","article-title":"Diagnostic value combining tumor and inflammatory markers in lung cancer","volume":"21","author":"Yoon","year":"2016","journal-title":"J Cancer Prev"},{"key":"B41","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.cca.2016.02.002","article-title":"Serum human epididymis protein 4 (HE4) may be a better tumor marker in early lung cancer","volume":"455","author":"Zeng","year":"2016","journal-title":"Clin Chim Acta"},{"key":"B42","first-page":"19014","article-title":"Value of serum marker HE4 in pulmonary carcinoma diagnosis","volume":"8","author":"Tang","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e0146063","DOI":"10.1371\/journal.pcne.0146063","article-title":"Serum biomarkers associated with clinical outcomes fail to predict brain metastases in patients with stage IV non-small cell lung cancers","volume":"11","author":"Li","year":"2016","journal-title":"PLoS One"},{"key":"B44","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s12094-015-1375-y","article-title":"Serum human epididymis protein 4 is associated with the treatment response of concurrent chemoradiotherapy and prognosis in patients with locally advanced non-small cell lung cancer","volume":"18","author":"Lan","year":"2016","journal-title":"Clin Transl Oncol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"e0128836","DOI":"10.1371\/journal.pone.0128836","article-title":"Serum HE4: an independent prognostic factor in non-small cell lung cancer","volume":"10","author":"Lamy","year":"2015","journal-title":"PLoS One"},{"key":"B46","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3779\/j.issn.1009-3413.2015.03.10","article-title":"Advances of human epididymis protein 4 in lung cancer","volume":"18","author":"Ma","year":"2015","journal-title":"Chin J Lung Cancer"},{"key":"B47","first-page":"5568","article-title":"Expression level of serum human epididymis 4 and its prognostic significance in human non-small cell lung cancer","volume":"7","author":"Jiang","year":"2014","journal-title":"Int J Clin Exp Med"},{"key":"B48","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3233\/CBM-140399","article-title":"Serum biomarkers for assessing histology and outcomes in patients with metastatic lung cancer","volume":"14","author":"Lou","year":"2014","journal-title":"Cancer Biomark"},{"key":"B49","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1007\/s13277-012-0499-8","article-title":"Serum level of HE4 is closely associated with pulmonary adenocarcinoma progression","volume":"33","author":"Yamashita","year":"2012","journal-title":"Tumour Biol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s13277-010-0118-5","article-title":"Prognostic significance of HE4 expression in pulmonary adenocarcinoma","volume":"32","author":"Yamashita","year":"2011","journal-title":"Tumour Biol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1007\/s13277-012-0356-9","article-title":"Serum HE4 as a diagnostic and prognostic marker for lung cancer","volume":"33","author":"Iwahori","year":"2012","journal-title":"Tumour Biol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s13277-011-0252-8","article-title":"Splice variant HE4-V3 expression is associated with favorable prognosis in pulmonary adenocarcinoma","volume":"33","author":"Tokuishi","year":"2012","journal-title":"Tumour Biol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3892\/mco.2016.919","article-title":"A new marker for breast cancer diagnosis, human epididymis protein 4: a preliminary study","volume":"5","author":"G\u00fcnd\u00fcz","year":"2016","journal-title":"Mol Clin Oncol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1097\/RCT.0000000000000390","article-title":"The use of breast magnetic resonance imaging parameters to identify possible signaling pathways of a serum biomarker, HE4","volume":"40","author":"Durur-Karakaya","year":"2016","journal-title":"J Comput Assist Tomogr"},{"key":"B55","doi-asserted-by":"publisher","first-page":"2956","DOI":"10.3390\/ijms16022956","article-title":"Expression and diagnostic value of HE4 in pancreatic adenocarcinoma","volume":"16","author":"Huang","year":"2015","journal-title":"Int J Mol Sci"},{"key":"B56","article-title":"Recombinant HE4 protein promotes proliferation of pancreatic and endometrial cancer cell lines","volume":"35","author":"Lu","year":"2015","journal-title":"Oncol Rep"},{"key":"B57","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1007\/s13277-014-2858-0","article-title":"The human epididymis protein 4 acts as a prognostic factor and promotes progression of gastric cancer","volume":"36","author":"Guo","year":"2015","journal-title":"Tumour Biol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/bjc.1995.72","article-title":"Proliferating cell nuclear antigen (PCNA) immunostaining \u2013 a prognostic factor in ovarian cancer?","volume":"71","author":"Thomas","year":"1995","journal-title":"Br J Cancer"},{"key":"B59","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/nrc2657","article-title":"P21 in cancer: intricate networks and multiple activities","volume":"9","author":"Abbas","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"B60","doi-asserted-by":"publisher","first-page":"332","DOI":"10.3389\/fonc.2017.00332","article-title":"Human epididymis protein 4 promotes events associated with metastatic ovarian cancer via regulation of the extracelluar matrix","volume":"7","author":"Ribeiro","year":"2018","journal-title":"Front Oncol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1476-4598-13-243","article-title":"Human epididymis protein 4 in association with Annexin II promotes invasion and metastasis of ovarian cancer cells","volume":"13","author":"Zhuang","year":"2014","journal-title":"Mol Cancer"},{"key":"B62","first-page":"3133","article-title":"Effect of human epididymis protein 4 gene silencing on the malignant phenotype in ovarian cancer","volume":"124","author":"Zou","year":"2011","journal-title":"Chin Med J (Engl)"},{"key":"B63","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.gendis.2014.12.002","article-title":"Targeting matrix metalloproteinases in cancer: bringing new life to old ideas","volume":"2","author":"Cathcart","year":"2015","journal-title":"Genes Dis"},{"key":"B64","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/nature03096","article-title":"Stromal fibroblasts in cancer initiation and progression","volume":"432","author":"Bhowmick","year":"2004","journal-title":"Nature"},{"key":"B65","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/nrc1877","article-title":"Fibroblasts in cancer","volume":"6","author":"Kalluri","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"B66","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/prca.201300105","article-title":"Cathepsin B: multiple roles in cancer","volume":"8","author":"Aggarwal","year":"2014","journal-title":"Proteomics Clin Appl"},{"key":"B67","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/j.1750-3639.2005.tb00118.x","article-title":"Proteases and glioma angiogenesis","volume":"15","author":"Lakka","year":"2005","journal-title":"Brain Pathol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1517\/14728222.2013.740461","article-title":"Cathepsin B as a cancer target","volume":"17","author":"Gondi","year":"2013","journal-title":"Expert Opin Ther Targets"},{"key":"B69","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1111\/j.1751-1097.2011.01062.x","article-title":"MTHPC-mediated photodynamic treatment up-regulates the cytokines VEGF and IL-1alpha","volume":"88","author":"Dabkeviciene","year":"2012","journal-title":"Photochem Photobiol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jss.2007.08.014","article-title":"Interleukin-1\u03b1 enhances angiogenesis and is associated with liver metastatic potential in human gastric cancer cell lines","volume":"148","author":"Ma","year":"2008","journal-title":"J Surg Res"},{"key":"B71","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1111\/j.0022-202X.2005.23629.x","article-title":"High invasive melanoma cells induce matrix metalloproteinase-1 synthesis in fibroblasts by interleukin-1alpha and basic fibroblast growth factor-mediated mechanisms","volume":"124","author":"L\u00f6ffek","year":"2005","journal-title":"J Invest Dermatol"},{"key":"B72","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.12354","article-title":"A module of inflammatory cytokines defines resistance of colorectal cancer to EGFR inhibitors","volume":"7","author":"Gelfo","year":"2016","journal-title":"Oncotarget"},{"key":"B73","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.12590","article-title":"Interleukin-1 blockade overcomes erlotinib resistance in head and neck squamous cell carcinoma","volume":"7","author":"Stanam","year":"2016","journal-title":"Oncotarget"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.3892\/or.2016.4926","article-title":"Analysis of the gene expression profile in response to human epididymis protein 4 in epithelial ovarian cancer cells","volume":"36","author":"Zhu","year":"2016","journal-title":"Oncol Rep"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1126\/science.285.5430.1028","article-title":"Integrin signaling","volume":"285","author":"Giancotti","year":"1999","journal-title":"Science"},{"key":"B76","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1242\/jcs.175539","article-title":"Focal-adhesion-independent integrin-\u03b1v regulation of FAK and c-Myc is necessary for 3D skin formation and tumor invasion","volume":"128","author":"Duperret","year":"2015","journal-title":"J Cell Sci"},{"key":"B77","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nrc2748","article-title":"Integrins in cancer: biological implications and therapeutic opportunities","volume":"10","author":"Desgrosellier","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"B78","doi-asserted-by":"publisher","first-page":"28693","DOI":"10.18632\/oncotarget.4981","article-title":"Molecular and clinical profiles of syndecan-1 in solid and hematological cancer for prognosis and precision medicine","volume":"6","author":"Akl","year":"2015","journal-title":"Oncotarget"},{"key":"B79","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.matbio.2011.10.001","article-title":"Molecular functions of syndecan-1 in disease","volume":"31","author":"Teng","year":"2012","journal-title":"Matrix Biol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/j.1365-2184.2004.00306.x","article-title":"Extra-cellular matrix in vascular networks","volume":"37","author":"Bou-Gharios","year":"2004","journal-title":"Cell Prolif"},{"key":"B81","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3109\/08830189509056711","article-title":"Regulation of type I collagen genes expression","volume":"12","author":"Karsenty","year":"1995","journal-title":"Int Rev Immunol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"2792","DOI":"10.1038\/srep02792","article-title":"Nuclear targeting of dystroglycan promotes the expression of androgen regulated transcription factors in prostate cancer","volume":"3","author":"Matthew","year":"2013","journal-title":"Sci Rep"},{"key":"B83","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/345315a0","article-title":"Deficiency of glycoprotein component of the dystrophin complex in dystrophic muscle deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle","volume":"345","author":"Ervasti","year":"1990","journal-title":"Nature"},{"key":"B84","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1083\/jcb.130.1.79","article-title":"Non-muscle alpha-dystroglycan is involved in epithelial development","volume":"130","author":"Durbeej","year":"1995","journal-title":"J Cell Biol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/j.1365-2559.2008.03157.x","article-title":"Expression of beta-dystroglycan is reduced or absent in many human carcinomas","volume":"53","author":"Cross","year":"2008","journal-title":"Histopathology"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.2174\/092986708785132834","article-title":"Laminin-332-integrin interaction: a target for cancer therapy?","volume":"15","author":"Tsuruta","year":"2008","journal-title":"Curr Med Chem"},{"key":"B87","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1158\/0008-5472.CAN-04-3924","article-title":"Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas","volume":"65","author":"Drapkin","year":"2005","journal-title":"Cancer Res"},{"key":"B88","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1002\/(SICI)1097-0215(19960208)65:4<406::AID-IJC2>3.0.CO;2-0","article-title":"Serological and immunochemical analysis of Lewis y (Ley) blood group antigen expression in epithelial ovarian cancer","volume":"65","author":"Yin","year":"1996","journal-title":"Int J Cancer"},{"key":"B89","first-page":"1482","article-title":"Expression and correlation of Lewis y antigen and integrins a5 and b1 in ovarian serous and mucinous carcinoma","volume":"20","author":"Li","year":"2010","journal-title":"Int J Gynecol Cancer"},{"key":"B90","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/1097-0215(20000701)87:1<79::AID-IJC12>3.0.CO;2-L","article-title":"Immunization of ovarian cancer patients with a synthetic Lewis(y)-protein conjugate vaccine: a phase 1 trial","volume":"87","author":"Sabbatini","year":"2000","journal-title":"Int J Cancer"},{"key":"B91","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.ygyno.2015.05.023","article-title":"A phase II trial with anti-Lewis-Y monoclonal antibody (hu3S193) for the treatment of platinum resistant\/refractory ovarian, fallopian tube and primary peritoneal carcinoma","volume":"138","author":"Smaletz","year":"2015","journal-title":"Gynecol Oncol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1007\/s12032-014-0920-9","article-title":"Expression of CD147 and Lewis y antigen in ovarian cancer and their relationship to drug resistance","volume":"31","author":"Gao","year":"2014","journal-title":"Med Oncol"},{"key":"B93","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1756-9966-32-36","article-title":"Expression of Lewis y antigen and integrin \u03b1v, \u03b23 in ovarian cancer and their relationship with chemotherapeutic drug resistance","volume":"32","author":"Gao","year":"2013","journal-title":"J Exp Clin Cancer Res"},{"key":"B94","doi-asserted-by":"publisher","first-page":"11024","DOI":"10.3390\/ijms140611024","article-title":"Chemoresistance is associated with MUC1 and lewis y antigen expression in ovarian epithelial cancers","volume":"14","author":"Zhang","year":"2013","journal-title":"Int J Mol Sci"},{"key":"B95","doi-asserted-by":"publisher","first-page":"e57250","DOI":"10.1371\/journal.pone.0057250","article-title":"High expression of Lewis y antigen and CD44 is correlated with resistance to chemotherapy in epithelial ovarian cancers","volume":"8","author":"Hu","year":"2013","journal-title":"PLoS One"},{"key":"B96","doi-asserted-by":"publisher","first-page":"15588","DOI":"10.3390\/ijms131215588","article-title":"Elevated levels of Lewis Y and integrin \u03b15\u03b21 correlate with chemotherapeutic drug resistance in epithelial ovarian carcinoma","volume":"13","author":"Hu","year":"2012","journal-title":"Int J Mol Sci"},{"key":"B97","doi-asserted-by":"publisher","first-page":"7323","DOI":"10.3390\/ijms12117323","article-title":"Increase in docetaxel-resistance of ovarian carcinoma-derived RMG-1 cells with enhanced expression of Lewis Y antigen","volume":"12","author":"Zhang","year":"2011","journal-title":"Int J Mol Sci"},{"key":"B98","doi-asserted-by":"publisher","first-page":"e68994","DOI":"10.1371\/journal.pone.0068994","article-title":"Co-expression of Lewis y antigen with human epididymis protein 4 in ovarian epithelial carcinoma","volume":"8","author":"Zhuang","year":"2013","journal-title":"PLoS One"},{"key":"B99","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.biochi.2014.06.022","article-title":"Overexpression of Lewis y antigen promotes human epididymis protein 4-mediated invasion and metastasis of ovarian cancer cells","volume":"105","author":"Zhuang","year":"2014","journal-title":"Biochimie"},{"key":"B100","first-page":"833","article-title":"Lewis(y) antigen stimulates the growth of ovarian cancer cells via regulation of the epidermal growth factor receptor pathway","volume":"23","author":"Liu","year":"2010","journal-title":"Oncol Rep"},{"key":"B101","doi-asserted-by":"publisher","first-page":"3446","DOI":"10.1002\/cncr.28864","article-title":"The MAPK pathway across different malignancies: a new perspective","volume":"120","author":"Burotto","year":"2014","journal-title":"Cancer"},{"key":"B102","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1161\/01.ATV.0000256471.22437.88","article-title":"Heparin cofactor II modulates the response to vascular injury","volume":"27","author":"Tollefsen","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1002\/path.4421","article-title":"Heparin co-factor II enhances cell motility and promotes metastasis in non-small cell lung cancer","volume":"235","author":"Liao","year":"2015","journal-title":"J Pathol"},{"key":"B104","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/j.cell.2014.01.040","article-title":"Serpins promote cancer cell survival and vascular co-option in brain metastasis","volume":"156","author":"Valiente","year":"2014","journal-title":"Cell"},{"key":"B105","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s12307-011-0064-9","article-title":"The role of annexin A2 in tumorigenesis and cancer progression","volume":"4","author":"Lokman","year":"2011","journal-title":"Cancer Microenviron"},{"key":"B106","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.2353\/ajpath.2007.060850","article-title":"Tissue plasminogen activator induces pancreatic cancer cell proliferation by a non-catalytic mechanism that requires extracellular signal-regulated kinase 1\/2 activation through epidermal growth factor receptor and annexin A2","volume":"170","author":"Ortiz-Zapater","year":"2007","journal-title":"Am J Pathol"},{"key":"B107","doi-asserted-by":"publisher","first-page":"7894","DOI":"10.1038\/sj.onc.1210588","article-title":"Gene expression and the biological phenotype of papillary thyroid carcinomas","volume":"26","author":"Delys","year":"2007","journal-title":"Oncogene"},{"key":"B108","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.4049\/jimmunol.179.5.3297","article-title":"Urokinase-type plasminogen activator stimulation of monocyte matrix metalloproteinase-1 production is mediated by plasmin-dependent signaling through annexin A2 and inhibited by inactive plasmin","volume":"179","author":"Zhang","year":"2007","journal-title":"J Immunol"},{"key":"B109","doi-asserted-by":"publisher","first-page":"7009","DOI":"10.1007\/s13277-014-1836-x","article-title":"Can HE4 predict platinum response during first-line chemotherapy in ovarian cancer?","volume":"35","author":"Angioli","year":"2014","journal-title":"Tumour Biol"},{"key":"B110","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/1757-2215-7-62","article-title":"Serum HE4, CA125, YKL-40, bcl-2, cathepsin-L and prediction optimal debulking surgery, response to chemotherapy in ovarian cancer","volume":"7","author":"Chudecka-G\u0142az","year":"2014","journal-title":"J Ovarian Res"},{"key":"B111","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1016\/j.celrep.2018.01.053","article-title":"Commonly occurring cell subsets in high-grade serous ovarian tumors identified by single-cell mass cytometry","volume":"22","author":"Gonzalez","year":"2018","journal-title":"Cell Rep"},{"key":"B112","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.ygyno.2012.11.040","article-title":"Can the preoperative HE4 level predict optimal cytoreduction in patients with advanced ovarian carcinoma?","volume":"128","author":"Angioli","year":"2013","journal-title":"Gynecol Oncol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2017-1176","article-title":"Prognostic value of HE4 in patients with ovarian cancer","author":"Yuan","year":"2018","journal-title":"Clin Chem Lab Med"},{"key":"B114","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1158\/1535-7163.MCT-14-1051","article-title":"Silencing Egr1 attenuates radiation-induced apoptosis in normal tissues while killing cancer cells and delaying tumor growth","author":"Zhao","year":"2015","journal-title":"Mol Cancer Ther"},{"key":"B115","doi-asserted-by":"publisher","first-page":"e25676","DOI":"10.1371\/journal.pone.0025676","article-title":"Coordinated sumoylation and ubiquitination modulate EGF induced EGR1 expression and stability","volume":"6","author":"Manente","year":"2011","journal-title":"PLoS One"},{"key":"B116","doi-asserted-by":"publisher","first-page":"3419","DOI":"10.3390\/ijms16023419","article-title":"Three-dimensional collagen type i matrix up-regulates nuclear isoforms of the microtubule associated protein tau implicated in resistance to paclitaxel therapy in ovarian carcinoma","volume":"16","author":"Gurler","year":"2015","journal-title":"Int J Mol Sci"},{"key":"B117","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s13277-012-0507-z","article-title":"Tau expression correlated with breast cancer sensitivity to taxanes-based neoadjuvant chemotherapy","volume":"34","author":"Wang","year":"2013","journal-title":"Tumour Biol"},{"key":"B118","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s00280-013-2108-y","article-title":"Regulation of microtubule-associated protein tau (MAPT) by miR-34c-5p determines the chemosensitivity of gastric cancer to paclitaxel","volume":"71","author":"Wu","year":"2013","journal-title":"Cancer Chemother Pharmacol"},{"key":"B119","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/sj.bjc.6602753","article-title":"Do septins have a role in cancer?","volume":"93","author":"Russell","year":"2005","journal-title":"Br J Cancer"},{"key":"B120","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1126\/science.296.5573.1655","article-title":"The phosphoinositide 3-kinase pathway","volume":"296","author":"Cantley","year":"2002","journal-title":"Science"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2014.00192","article-title":"Estrogen biosynthesis and action in ovarian cancer","volume":"5","author":"Mungenast","year":"2014","journal-title":"Front Endocrinol"},{"key":"B122","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.jsbmb.2014.02.010","article-title":"Estrogen signaling crosstalk: implications for endocrine resistance in ovarian cancer","volume":"143","author":"Ribeiro","year":"2014","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B123","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1172\/JCI18698","article-title":"Role of Foxa-2 in adipocyte metabolism and differentiation","volume":"112","author":"Wolfrum","year":"2003","journal-title":"J Clin Invest"},{"key":"B124","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s10549-015-3553-6","article-title":"FOXA2 mRNA expression is associated with relapse in patients with triple-negative\/basal-like breast carcinoma","volume":"153","author":"Perez-Balaguer","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"B125","doi-asserted-by":"publisher","first-page":"19435","DOI":"10.1038\/srep19435","article-title":"Squalene epoxidase is a bona fide oncogene by amplification with clinical relevance in breast cancer","volume":"6","author":"Brown","year":"2016","journal-title":"Sci Rep"},{"key":"B126","doi-asserted-by":"publisher","first-page":"8363","DOI":"10.1074\/jbc.M115.699546","article-title":"Cholesterol-mediated degradation of 7-dehydrocholesterol reductase switches the balance from cholesterol to vitamin D synthesis","volume":"291","author":"Prabhu","year":"2016","journal-title":"J Biol Chem"},{"key":"B127","doi-asserted-by":"publisher","first-page":"41404","DOI":"10.1038\/srep41404","article-title":"Cholesterol synthetase DHCR24 induced by insulin aggravates cancer invasion and progesterone resistance in endometrial carcinoma","volume":"7","author":"Dai","year":"2017","journal-title":"Sci Rep"},{"key":"B128","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1194\/jlr.M056986","article-title":"The terminal enzymes of cholesterol synthesis, DHCR24 and DHCR7, interact physically and functionally","volume":"56","author":"Luu","year":"2015","journal-title":"J Lipid Res"},{"key":"B129","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.plipres.2013.09.002","article-title":"Desmosterol and DHCR24: unexpected new directions for a terminal step in cholesterol synthesis","volume":"52","author":"Zerenturk","year":"2013","journal-title":"Prog Lipid Res"},{"key":"B130","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1016\/j.celrep.2015.08.023","article-title":"Endogenous sterol metabolites regulate growth of EGFR\/KRAS-dependent tumors via LXR","volume":"12","author":"Gabitiva","year":"2015","journal-title":"Cell Rep"},{"key":"B131","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1158\/2159-8290.CD-12-0031","article-title":"Targeting C4-demethylating genes in the cholesterol pathway sensitizes cancer cells to EGF receptor inhibitors via increased EGF receptor degradation","volume":"3","author":"Sukhanova","year":"2013","journal-title":"Cancer Discov"},{"key":"B132","doi-asserted-by":"publisher","first-page":"5500","DOI":"10.1038\/srep05500","article-title":"HE4 expression is associated with hormonal elements and mediated by importin-dependent nuclear translocation","volume":"4","author":"Lokich","year":"2014","journal-title":"Sci Rep"},{"key":"B133","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/nrg1655","article-title":"DNA methylation and human disease","volume":"6","author":"Robertson","year":"2005","journal-title":"Nat Rev Genet"},{"key":"B134","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1101\/gad.947102","article-title":"DNA methylation patterns and epigenetic memory","volume":"16","author":"Bird","year":"2002","journal-title":"Genes Dev"},{"key":"B135","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13048-015-0210-y","article-title":"WAP four-disulfide core domain protein 2 gene(WFDC2) is a target of estrogen in ovarian cancer cells","volume":"9","author":"Chen","year":"2016","journal-title":"J Ovarian Res"},{"key":"B136","doi-asserted-by":"publisher","first-page":"2324709618760080","DOI":"10.1177\/2324709618760080","article-title":"A recurrent platinum refractory ovarian cancer patient with a partial response after RRx-001 resensitization to platinum doublet","volume":"6","author":"Cottrill","year":"2018","journal-title":"J Investig Med High Impact Case Rep"},{"key":"B137","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.2217\/pgs.12.137","article-title":"Differing clinical impact of BRCA1 and BRCA2 mutations in serous ovarian cancer","volume":"13","author":"Liu","year":"2012","journal-title":"Pharmacogenomics"},{"key":"B138","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12916-017-0884-7","article-title":"Spotlight on landmark oncology trials: the latest evidence and novel trial designs","volume":"15","author":"Earl","year":"2017","journal-title":"BMC Med"},{"key":"B139","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s40661-016-0033-6","article-title":"The role of immune checkpoint inhibition in the treatment of ovarian cancer","volume":"3","author":"Gaillard","year":"2016","journal-title":"Gynecol Oncol Res Pract"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fonc.2018.00124\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T06:50:03Z","timestamp":1604213403000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fonc.2018.00124\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,24]]},"references-count":139,"alternative-id":["10.3389\/fonc.2018.00124"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2018.00124","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,24]]},"article-number":"124"}}